January 2014 FDA Recall Heparin Sodium by Fresenius Kabi Usa, Llc
D-1148-2014 - Subpotent; 18 month time point

This Class II drug recall was voluntarily initiated by Fresenius Kabi Usa, Llc on January 22, 2014 for the product Heparin Sodium. The FDA reported the reason for recall as subpotent; 18 month time point. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1148-2014

Reason for Recall
Subpotent; 18 month time point
Initiated
01-22-2014
Reported
03-12-2014
Quantity
161,650 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Fresenius Kabi USA, LLC
Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11, 25 vials in tray, each boxed vial individually labeled as: Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11.

Batch or Lot Expiration Information

Lot# Lot Number: 6004137, Expiration date: 06/2014